LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
155,500
-300 (-0.19%)
Aug 14, 2025, 2:40 PM KST
64.72%
Market Cap 5.65T
Revenue (ttm) 146.42B
Net Income (ttm) 24.86B
Shares Out 36.25M
EPS (ttm) 671.86
PE Ratio 231.90
Forward PE 109.23
Dividend n/a
Ex-Dividend Date n/a
Volume 318,541
Average Volume 517,732
Open 155,400
Previous Close 155,800
Day's Range 153,700 - 158,900
52-Week Range 79,400 - 157,900
Beta 0.83
RSI 67.91
Earnings Date Aug 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.